Project Grant HT94252510606
Award Date
9/30/25
Completion Date
9/29/27
Dollars Obligated
$620K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48202, USA
Similar Awards
The U.S. Defense Health Agency awarded a $292,260 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Henry Ford Health System in Detroit, Michigan. The grant, with a performance period from July 1, 2025 to June 30, 2028, will support research aimed at "Finding the Missing Link Between Pancreatic Neoplasia and Carcinoma." As a non-profit integrated healthcare provider and research organization, the Henry Ford Health System will leverage its...
The Defense Health Agency awarded a $523,663 Project Grant to the Henry Ford Health System - doing business as Henry Ford Hospital, a non-profit hospital in Detroit, Michigan. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), supports research to investigate the NETRIN G1 ligand as a new immunomodulatory target and early biomarker in pancreatic cancer. The project will be conducted from August 1, 2023 to July 31, 2026. Henry Ford Health System has...
The federal Project Grant award of $714,934.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) was awarded to the Henry Ford Health System in Detroit, Michigan to conduct research on "Finding the Missing Link Between Pancreatic Neoplasia and Carcinoma." The award has a performance period from July 1, 2025 to June 30, 2028. The Military Medical Research and Development program supports advanced biomedical research aimed at transforming...
This $911,999 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund research by the Henry Ford Health System in Detroit, Michigan to target mitochondrial metabolism in ovarian cancer. The award, effective April 1, 2024 through March 31, 2028, will support basic, translational, and clinical research aimed at developing new treatments, diagnostic tools, and preventive measures for this area of military medical importance....
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $532,000.00 in funding to the Henry Ford Health System in Detroit, MI. The grant supports research to investigate HDAC3 as a potential therapeutic target for Langerhans cell histiocytosis, a rare medical condition. The performance period for this grant runs from December 1, 2024 to November 30, 2027. As a prominent non-profit...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The Defense Health Agency awarded a $724,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Duke University. The grant, titled "Targeting Dormancy-Associated Immune Tolerance to Eliminate Residual Breast Cancer," will fund advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The research, to be conducted at Duke University's Office of Research Administration Division from March...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,844,306.00 Project Grant to the Regents of the University of Michigan on September 1, 2025. The grant, titled "COTARGETING NSD1/2 PARALOGS IN AR-DRIVEN CASTRATION-RESISTANT PROSTATE CANCER," will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will investigate innovative medical...
The Henry Ford Health System was awarded a $615,782 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 15, 2022 to July 14, 2025 to investigate paracrine pathways contributing to the growth and invasion of neurofibromas and the role of the cellular microenvironment. Through this research, the awardee aims to advance understanding of medical solutions for neurofibromas,...
The Department of Defense's Defense Health Agency awarded a $783,023 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. The grant supports a 3-year research project titled "A Precision-Medicine Approach to Targeting Acquired Therapeutic Resistance in RTK-Mutated NSCLC". This research aims to transform healthcare for military service members, veterans, and the broader...